| Predictive and prognostic molecular markers for cancer medicine S Mehta, A Shelling, A Muthukaruppan, A Lasham, C Blenkiron, G Laking, ... Therapeutic advances in medical oncology 2 (2), 125-148, 2010 | 254 | 2010 |
| Susceptibility to chronic inflammation: an update NA Nasef, S Mehta, LR Ferguson Archives of Toxicology 91, 1131-1141, 2017 | 94 | 2017 |
| ∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling H Campbell, N Fleming, I Roth, S Mehta, A Wiles, G Williams, C Vennin, ... Nature communications 9 (1), 254, 2018 | 68 | 2018 |
| Selective treatment of hypoxic tumor cells in vivo: phosphate pre‐prodrugs of nitro analogues of the duocarmycins M Tercel, GJ Atwell, S Yang, A Ashoorzadeh, RJ Stevenson, KJ Botting, ... Angewandte Chemie 123 (11), 2654-2657, 2011 | 53 | 2011 |
| The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer M Kazantseva, S Mehta, RA Eiholzer, G Gimenez, S Bowie, H Campbell, ... Cell death & disease 10 (9), 631, 2019 | 47 | 2019 |
| Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development M Kazantseva, RA Eiholzer, S Mehta, A Taha, S Bowie, I Roth, J Zhou, ... The Journal of pathology 246 (1), 77-88, 2018 | 43 | 2018 |
| Expression and role in glycolysis of human ADP-dependent glucokinase S Richter, JP Richter, SY Mehta, AM Gribble, AJ Sutherland-Smith, ... Molecular and cellular biochemistry 364, 131-145, 2012 | 39 | 2012 |
| A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology S Mehta, P Tsai, A Lasham, H Campbell, R Reddel, A Braithwaite, C Print Cancer Research 76 (24), 7151-7159, 2016 | 37 | 2016 |
| A novel EGR‐1 dependent mechanism for YB‐1 modulation of paclitaxel response in a triple negative breast cancer cell line A Lasham, SY Mehta, SJ Fitzgerald, AG Woolley, JI Hearn, DG Hurley, ... International journal of cancer 139 (5), 1157-1170, 2016 | 37 | 2016 |
| Why be one protein when you can affect many? The multiple roles of YB-1 in lung cancer and mesothelioma TG Johnson, K Schelch, S Mehta, A Burgess, G Reid Frontiers in cell and developmental biology 7, 221, 2019 | 31 | 2019 |
| Role of inflammation in pathophysiology of colonic disease: an update NA Nasef, S Mehta International journal of molecular sciences 21 (13), 4748, 2020 | 29 | 2020 |
| Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case N Ahmed Nasef, S Mehta, LR Ferguson Frontiers in Genetics 5, 64, 2014 | 27 | 2014 |
| Adaptive homeostasis and the p53 isoform network S Mehta, H Campbell, CJ Drummond, K Li, K Murray, T Slatter, ... EMBO reports 22 (12), e53085, 2021 | 25 | 2021 |
| Influence of a basic side chain on the properties of hypoxia-selective nitro analogues of the duocarmycins: Demonstration of substantial anticancer activity in combination with … M Tercel, HH Lee, SY Mehta, JJ Youte Tendoung, SY Bai, HDS Liyanage, ... Journal of Medicinal Chemistry 60 (13), 5834-5856, 2017 | 25 | 2017 |
| Anti-Inflammatory Activity of Fruit Fractions in Vitro, Mediated through Toll-Like Receptor 4 and 2 in the Context of Inflammatory Bowel Disease NA Nasef, S Mehta, P Murray, G Marlow, LR Ferguson Nutrients 6 (11), 5265-5279, 2014 | 23 | 2014 |
| Dephosphorylation of YB-1 is Required for Nuclear Localisation During G2 Phase of the Cell Cycle S Mehta, C McKinney, M Algie, CS Verma, S Kannan, R Harfoot, ... Cancers 12 (2), 315, 2020 | 21 | 2020 |
| A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation M Kazantseva, S Mehta, RA Eiholzer, N Hung, A Wiles, TL Slatter, ... Mammalian genome 29, 831-842, 2018 | 20 | 2018 |
| Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk RA Eiholzer, S Mehta, M Kazantseva, CJ Drummond, C McKinney, ... Cancers 12 (9), 2472, 2020 | 19 | 2020 |
| Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes SY Mehta, BC Morten, J Antony, L Henderson, A Lasham, H Campbell, ... Oncotarget 9 (49), 29146, 2018 | 19 | 2018 |
| Extracts of Feijoa inhibit Toll-like receptor 2 signaling and Activate Autophagy Implicating a role in dietary control of IBD NA Nasef, S Mehta, P Powell, G Marlow, T Wileman, LR Ferguson PloS one 10 (6), e0130910, 2015 | 19 | 2015 |
